Будущее медицины: Ваше здоровье в ваших руках - Эрик Тополь

41. "The Ninety-Five Theses," Wikipedia, accessed August 13, 2014, http://en.wikipedia.org/wiki/ The_Ninety-Five_Theses.

42. J. Katz, The Silent World of Doctor and Patient (Baltimore, MD: Johns Hopkins University Press, 1984), 7–8.

43. American Medical Association, Code of Medical Ethics, 1847, http://www.ama-assn.org/ama/pub/about-ama/our-history/history-ama-ethics.page.

44. Eisenstein, The Printing Press as an Agent of Change, 303.

45. "Sacrosanctum Concilium," Wikipedia, accessed August 13, 2014, http://en.wikipedia.org/wiki/ Sacrosanctum_Concilium.

46. "Ad Orientem," Wikipedia, accessed August 13, 2013, http://en.wikipedia.org/wiki/Ad_orientem.

47. J. Schuessler, "Wired: Putting a Writer and Readers to a Test," New York Times, November 30, 2013, http://www.nytimes.com/2013/11/30/books/arnon-grunberg-is-writing-while-connected-to-electrodes.html.

48. "MIT Researchers Create Wearable Books," PressTV, January 30, 2014, http://www.presstv.ir/detail/2014/01/30/348428/mit-researchers-create-wearable-books/.

Глава 4

1. A. Jolie, «My Medical Choice,» New York Times, May 14, 2013, http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html.

2. "23andMe and the FDA: A Regulator Brings a Genetic Company to a Halt," The Economist, November 30, 2013, http://www.economist.com/news/business/21590941-regulator-brings-genetics-company-halt-and-fda/print.

3. M. Dowd, "Cascading Confessions," New York Times, May 15, 2013, http://www.nytimes.com/2013/05/15/opinion/dowd-cascading-confessions.html.

4. "Angelina Jolie," Wikipedia, accessed August 13, 2014, http://en.wikipedia.org/wiki/Angelina_Jolie.

5. K. Blake, "Angelina Jolie Effect: Breast Cancer Awareness vs. Knowledge," Health News from Health Canal, December 20, 2013, http://www.healthcanal.com/cancers/breast-cancer/46121-angelina-jolie-effect-breast-cancer-awareness-vs-knowledge.html.

6. A. L. Caplan, "The Actress, the Court, and What Needs to Be Done to Guarantee the Future of

Clinical Genomics," PLoS Biology 11, no. 9 (2013): e1001663.

7. T. E. Board, "Angelina Jolie's Disclosure," New York Times, May 18, 2013, http://www.nytimes.com/2013/05/18/opinion/angelina-jolies-disclosure.html.

8. D. L. G. Borzekowski et al., "The Angelina Effect: Immediate Reach, Grasp, and Impact of Going Public," Genetics in Medicine, December 19, 2013, http://www.nature.com/gim/journal/vaop/ ncurrent/pdf/gim2013181a.pdf.

9. A. Breznican, "Angelina Jolie Recounts 'All the Kindness' That Helped Her Through Her HealthScare," Entertainment Weekly, March 5, 2014, http://insidemovies.ew.com/2014/03/05/angelina-jolie-health-exclusive/.

10. E. Christakis, "Angelina's Mastectomy: Altered Bodies Are Already the Norm," TIME, May 15, 2013, http://ideas.time.com/2013/05/15/angelinas-surgery-altered-body-parts-are-already-the-norm/print/.

11. L. Rothman, "Angelina Jolie's Public-Image Turnaround," TIME, May 14, 2013, http://entertainment.time.com/2013/05/14/angelina-jolies-public-image-turnaround/print/.

12. J. Kluger and A. Park, "The Angelina Effect," TIME, May 27, 2013, http://content.time.com/time/subscriber/ printout/0,8816,2143559,00.html.

13. D. Kotz, "Increase in Breast Cancer Gene Screening: The Angelina Jolie Effect," Boston Globe, December 3, 2013, http://www.boston.com/lifestyle/health/blogs/daily-dose/2013/12/03/increase-breast-cancer-gene-screening-the-angelina-jolie-effect/2HsXjeZh6MdTE5B8T3nGMI/blog.html.

14. L. Corner, "Why Are More Women Having Mastectomies?" The Independent, December 1, 2013, http://www.independent.co.uk/life-style/health-and-families/features/why-are-more-women-having-mastectomies-8969889.html.

15. P. Orenstein, "Reacting to Angelina Jolie's Breast Cancer News," 6th Floor, May 15, 2013, http://6thfloor.blogs.nytimes.com/2013/05/15/reacting-to-angelina-jolies-breast-cancer-news/.

16. K. Pickert, "Lessons from Angelina: The Tricky Calculus of Cancer Testing," TIME, May 15, 2013, http://nation.time.com/2013/05/15/lessons-from-angelina-the-tricky-calculus-of-cancer-testing/print/.

17. P. B. Bach, "A Pioneering Force," Town & Country, October 2013, http://www.townandcountrymag.com/print-this/dr-kristi-funk-pink-lotus?page=all.

18. K. Funk, "A Patient's Journey: Angelina Jolie," Breast Cancer 101, May 14, 2013, http://pinklotusbreastcenter.com/breast-cancer-101/2013/05/a-patients-journey-angelina-jolie/.

19. A. W. Kepler, "Angelina Jolie's Aunt Dies of Breast Cancer," New York Times, May 27, 2013, http://artsbeat.blogs.nytimes.com/2013/05/27/angelina-jolies-aunt-dies-of-breast-cancer/.

20. M. Melton, "Dr. Kristi Funk," Los Angeles Magazine, September 10, 2013, http://www.lamag.com/lawoman/article/2013/09/10/dr-kristi-funk.

21. R. C. Rabin, "No Easy Choices on Breast Reconstruction," New York Times, May 20, 2013, http://well.blogs.nytimes.com/2013/05/20/no-easy-choices-on-breast-reconstruction/.

22. D. Grady, T. Parker-Pope, and P. Belluck, "Jolie's Disclosure of Preventive Mastectomy High– lights Dilemma," New York Times, May 15, 2013, http://www.nytimes.com/2013/05/15/health/angelina-jolies-disclosure-highlights-a-breast-cancer-dilemma.html.

23. H. D. Nelson et al., "Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA– Related Cancer in Women: A Systematic Review to Update the US Preventive Services Task Force Recommendation," Annals of Internal Medicine 160 (2014): 255–266.

24. G. Rennert et al., "Clinical Outcomes of Breast Cancer in Carriers of BRCA1 and BRCA2 Mutations," New England Journal of Medicine 357, no. 2 (2007): 115–123.

25. R. Winslow, "Early Ovary Removal Reduces Long-Term Cancer Risk: Study," Wall Street Journal, February 24, 2013, http://online.wsj.com/news/article_email/ SB10001424052702304834704579403421175065210 -lMyQ jAxMTA0MDIwNTEyNDUyWj.

26. A. P. Finch et al., "Impact of Oophorectomy on Cancer Incidence and Mortality in Women with a BRCA1 or BRCA2 Mutation," Journal of Clinical Oncology 32, no. 15 (2014): 1549–1554.

27. N. D. Kauff et al., "Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation," New England Journal of Medicine 346, no. 21 (2002): 1609–1615.

28. S. J. Hoffman and C. Tan, "Following Celebrities' Medical Advice: Meta-Narrative Analysis," British Medical Journal 347 (2013): f 7151.

29. J. Bulluz and S. J. Hoffman, "Katie Couric and the Celebrity Medicine Syndrome," Los Angeles Times, December 18, 2013, http://www.latimes.com/opinion/commentary/la-oe-hoffman-celebrities-health-advice-20131218,0,3861833.story.

30. K. Kamenova, A. Reshef, and T. Caulfield, "Angelina Jolie's Faulty Gene: Newspaper Coverage of a Celebrity's Preventive Bilateral Mastectomy in Canada, the United States, and the United Kingdom," Genetics in Medicine 16, no. 7 (2013): 522–528, http://www.nature.com/gim/journal/ vaop/ncurrent/full/gim2013199a.html.

31. "Myriad Genetics Q1 Revenues Shoot up 52 Percent; Angelina Jolie Effect Cited," GenomeWeb, November 6, 2013, http://www.genomeweb.com/clinical-genomics/myriad-genetics-q1-revenues-shoot-52-percent-angelina-jolie-effect-cited.

32. R. C. Rabin, "In Israel, a Push to Screen for Cancer Gene Leaves Many Conflicted," New York Times, November 27, 2013, http://www.nytimes.com/2013/11/27/health/in-israel-a-push-to-screen-for-cancer-gene-leaves-many-conflicted.html.

33. E. Murphy, "Inside 23andMe Founder Anne Wojcicki's $99 DNA Revolution," Fast Company, October 14, 2013: http://www.fastcompany.com/3018598/for-99-this-ceo-can-tell-you-what-might-kill-you-inside-23andme-founder-anne-wojcickis-dna-r.

34. FDA, "Inspections, Compliance, Enforcement, and Criminal Investigations: Warning Letter to Ann Wojcicki," November 22, 2013, http://www.fda.gov/ICECI/EnforcementActions/ WarningLetters/2013/ucm376296.htm.

35. A. Pollack, "FDA Orders Genetic Testing Firm to Stop Selling DNA Analysis Service," New York Times, November 26, 2013, http://www.nytimes.com/2013/11/26/business/fda-demands-a-halt-to-a-dna-test-kits-marketing.html.

36. A. Pollack, "Genetic Tester to Stop Providing Data on Health Risks," New York Times, December 6, 2013, http://www.nytimes.com/2013/12/06/business/genetic-tester-to-stop-providing-data-on-health-risks.html.

37. F. Polli, "Why 23andMe Deserves a Second Chance," Forbes, January 14, 2014, http://www.forbes.com/sites/fridapolli/2014/01/14/why-23andme-deserves-a-second-chance/.

38. T. Ray, "Facing FDA Warning Letter and Lawsuit, Can 23andMe Stay True to Its DTC Credo in 15 Days?" GenomeWeb, December 4, 2013, http://www.genomeweb.com/print/1319176?utm_source=SilverpopMai%C9 PGx Uncertainty.

39. R. Rekhi, "A Government Ban on 23andMe's Genetic Testing Services Ignores Reality," The Guardian, December 4, 2013, http://www.theguardian.com/commentisfree/2013/dec/04/23andme-consumer-genomics-fda-ban-regulation/print.

40. R. Khan, "The FDA's Battle With 23andMe Won't Mean Anything in the Long Run," Slate, November 25, 2013, http://www.slate.com/blogs/future_tense/2013/11/25/fda _letter_to_23andme_won_t_mean_anything_in_the_long_run.html.

41. R. Khan and D. Mittelman, "Rumors of the Death of Consumer Genomics Are Greatly Exaggerated," Genome Biology 14 (2013): 139, http://genomebiology.com/2013/14/11/139.

42. C. J. Janssens, "It Is Game Over for 23andMe, and Rightly So," The Conversation, November 26, 2013, http://theconversation.com/it-is-game-over-for-23andme-and-rightly-so-20744.

43. L. Jamal, "What Do We Gain or Lose by Regulating 23andMe?" Berman Institute of Bioethics Bulletin, November 27, 2013, http://bioethicsbulletin.org/archive/what-do-we-gain-or-lose-by-regulating-23andme/print/.

44. T. Hay, "23andMe Flap With FDA Just a Bump in the Road, One Genetics-Testing Investor Says," Wall Street Journal, December 16, 2013, http://blogs.wsj.com/venturecapital/2013/12/16/23andme-flap-with-fda-just-a-bump-in-the-road-one-genetics-testing-investor-says/tab/print/.

45. H. Greely, "The FDA Drops an Anvil on 23andMe – Now What?" Law and Biosciences Blog, November 25, 2013, https://blogs.law.stanford.edu/lawandbiosciences/2013/11/25/the-fda-drops-an-anvil-on-23andme-now-what/.

46. M. F. Murray, "Why We Should Care About What We Get for 'Only $99' From a Personal Genomic Service," Annals of Internal Medicine 160, no. 7 (2014): 507–508.

47. G. Neff, "In the Battle Over Personal Health Data, 23andMe and the FDA Are Both Wrong," Slate, December 13, 2013, http://www.slate.com/blogs/future_tense/2013/ 12/13/_23andme_vs_the_fda_both_are_wrong.html.

48. R. Bailey, "Let My Genes Go! And Leave 23andMe Alone," Reason.com, November 29, 2013, http://reason.com/archives/2013/11/29/why-the-fda-should-leave-23andme-alone/print.

49. S. Usdin, "The Sky Isn't Falling," BioCentury, June 17, 2013, http://www.biocentury.com/biotech-pharma-news/politics/2013-06-17/scotus-myriad-protects-biotech-patenting-but-leaves-important-gray-areas-a13.

50. E. Vayena, "Direct-to-Consumer Genomics on the Scales of Autonomy," Journal of Medical Ethics, May 5, 2014, http://jme.bmj.com/content/early/2014/05/05/medethics-2014-102026.full.

51. J. K. Wagner, "The Sky Is Falling for Personal Genomics! Oh, Nevermind. It's Just a Cease & Desist Letter from the FDA to 23andMe," Genomics Law Report, December 3, 2013, http://www.genomicslawreport.com/index.php/2013/12/03/the-sky-is-falling-for-personal-genomics-oh-nevermind-its-just-a-cease-desist-letter-from-the-fda-to-23andme/.

52. "Doing the Genomic Revolution Right," Huffngton Post, December 20, 2013, http://www.huffingtonpost.com/tricia-page/doing-the-genomic-revolution-right_b_4480887.html?view=print&comm_ref=false.

53. A. J. Burke, "23andMe's FDA Battle Provokes Furious Debate," Techonomy, December 2, 2013, http://techonomy.com/2013/12/just-tip-iceberg-23andme-medicine/.

54. "Multiple Testing an Issue for 23andMe," Bits of DNA, November 30, 2013, http://liorpachter.wordpress.com/2013/11/30/23andme-genotypes-are-all-wrong/.

55. "23andMe: State of Debate," Bio-IT World, November 27, 2013, http://www.bio-itworld.com/2013/11/27/23andme-state-of-debate.html.

56. M. Hiltzik, "23andMe's Genetic Tests Are More Misleading Than Helpful," Los Angeles Times, December 15, 2013, http://www.latimes.com/business/la-fi-hiltzik-20131215,0,1359952.column.

57. K. Hill, "The FDA Just Ruined Your Plans to Buy 23andMe's DNA Test as a Christmas Present," Forbes, November 25, 2013, http://www.forbes.com/sites/kashmirhill/2013/11/25/fda-23andme/.

58. L. Kish, "The Social Conquest of Medicine: The 23andMe and Conflict," HL7 Standards, January 7, 2014, http://www.hl7standards.com/blog/2014/01/07/23andme/.

59. J. Kiss, "23andMe Admits FDA Order 'Significantly Slowed Up' New Customers," The Guardian, March 9, 2014, http://www.theguardian.com/technology/2014/mar/09/google-23andme-anne-wojcicki-genetics-healthcare-dna/print.

60. A. Krol, "Show, Don't Tell: 23andMe Pursues Health Research in the Shadow of the FDA,"Bio-IT World, March 24, 2014, http://www.bio-it world.com/2014/3/24/show-dont-tell-23andme-pursues-health-research-shadow-fda.html.

61. D. Kroll, "Why The FDA Can't Be Flexible With 23andMe," Forbes, November 28, 2013, http://www.forbes.com/sites/davidkroll/2013/11/28/why-the-fda-cant-be-flexible-with-23andme-by-law/.

62. P. Loftus, "23andMe Stops Genetic Test Marketing," Wall Street Journal, December 2, 2013, http://online.wsj.com/news/articles/ SB10001424052702304579404579234503409624522.

63. P. Loftus, "Genetic Test Service 23andMe Ordered to Halt Marketing by FDA," Wall Street Journal, November 25, 2013: http://online.wsj.com/news/articles/ SB10001424052702304281004579219893863966448.

64. P. Loftus and R. Winslow, "23andMe CEO Responds to FDA Warning Letter," Wall Street Journal, November 27, 2013, http://online.wsj.com/news/articles/ SB10001424052702303332904579224093983156448.